检验医学 ›› 2026, Vol. 41 ›› Issue (8): 779-786.DOI: 10.3969/j.issn.1673-8640.2026.08.010

• 论著 • 上一篇    下一篇

ADH-1A对肺腺癌细胞生物学行为的影响及临床验证

屈海燕, 朱伟君(), 李宁君, 陈福娟   

  1. 浙江省台州市立医院病理科浙江 台州 318000
  • 收稿日期:2024-09-29 修回日期:2025-10-22 出版日期:2026-08-30 发布日期:2026-08-24
  • 通讯作者: 朱伟君,E-mail:zhuliS_1978@163.com
  • 作者简介:屈海燕,女,1985年生,学士,主治医师,主要从事肿瘤病理研究。

Influence of ADH-1A on the cell biological behavior of lung adenocarcinoma and its clinical verification

QU Haiyan, ZHU Weijun(), LI Ningjun, CHEN Fujuan   

  1. Department of PathologyTaizhou Municipal HospitalTaizhou 318000,Zhejiang, China
  • Received:2024-09-29 Revised:2025-10-22 Online:2026-08-30 Published:2026-08-24

摘要:

目的 探讨乙醇脱氢酶1A(ADH-1A)蛋白表达对胰腺癌细胞生物学行为的影响,以及与肺腺癌(LUAD)患者临床病理特征及预后的相关性。方法 选取2013年1月—2017年12月浙江省台州市立医院LUAD患者172例。收集所有患者的临床资料,以及癌组织和癌旁组织,并检测ADH-1A表达。以ADH-1A阳性细胞<5%为ADH-1A阴性组(111例),≥5%为ADH-1A阳性组(61例)。对所有患者随访24个月,记录其总生存期和无进展生存期(PFS)。通过GEO数据库和Starbase数据库筛选LUAD患者的差异表达基因,并分析LUAD组织中ADH-1A的表达情况,及其与LUAD患者生存期的关系。将ADH-1A过表达质粒转染至A549细胞中,根据转染的质粒分为oe-ADH-1A组(转染ADH-1A过表达质粒)和oe-NC组(转染空质粒)。采用CCK-8试验、细胞增殖试验和划痕实验分析ADH-1A过表达对A549细胞增殖、迁移和侵袭能力的影响。采用Kaplan-Meier生存曲线评估LUAD患者的生存情况。采用Cox回归分析评估LUAD患者总生存期缩短的影响因素。结果 数据库分析结果显示,LUAD患者癌组织ADH-1A呈低表达(P<0.000 1),ADH-1A高表达的LUAD患者总生存期长于低表达患者(P=0.004 7)。LUAD患者癌组织ADH-1A蛋白阳性率显著低于癌旁组织(P<0.000 1)。ADH-1A阳性组总生存期和PFS显著长于ADH-1A阴性组(P<0.01)。过表达ADH-1A可抑制A549细胞的增殖、迁移和侵袭能力(P<0.000 1)。性别为女性、ADH-1A阴性为LUAD患者总生存期缩短的危险因素[风险比(HR)分别为1.686、0.501,95%可信区间(CI)分别为1.112~2.555、0.328~0.764,P<0.05]。结论 LUAD患者癌组织中ADH-1A呈低表达,上调其表达可抑制LUAD细胞的增殖和侵袭能力。ADH-1A或可作为LUAD的预后标志物和治疗靶点。

关键词: 乙醇脱氢酶1A, 肺腺癌, 细胞功能实验, 生存分析

Abstract:

Objective To investigate the effect of the expression of alcohol dehydrogenase 1A(ADH-1A) protein on the biological behavior of lung adenocarcinoma(LUAD) cells and the correlation with the pathological characteristics and prognosis of LUAD patients. Methods A total of 172 LUAD patients from Taizhou Municipal Hospital from January 2013 to December 2017 were enrolled. The clinical data,as well as cancer tissues and adjacent tissues,were collected,and the expression of ADH-1A was determined. The patients were classified into negative group(111 cases) with <5% ADH-1A positive cells and positive group(61 cases) with ≥5% ADH-1A positive cells. All the patients were followed up for 24 months,and the overall survival time and progression-free survival time(PFS) of the patients were recorded. The differentially expressed genes of LUAD patients were screened through the GEO database and Starbase database,and the expression of ADH-1A in LUAD tissues and its relationship with the survival period of LUAD patients were analyzed. The ADH-1A overexpression plasmid was transfected into A549 cells,and the oe-ADH-1A group(transfected with ADH-1A overexpression plasmid) and oe-NC group(transfected with empty plasmid) were classified according to the different transfection plasmids. The effects of ADH-1A overexpression on the proliferation,migration and invasion ability of A549 cells were analyzed by CCK-8 test,cell proliferation test and scratch test. The survival situation of LUAD patients was evaluated by Kaplan-Meier survival curve. The factors influencing the shortened overall survival period of LUAD patients were analyzed by Cox regression. Results The ADH-1A expression in the cancer tissues of LUAD patients was low(P<0.000 1).The overall survival time of LUAD patients with high ADH-1A expression was longer than that of those with low expression(P=0.004 7). The positive rate of ADH-1A protein in the cancer tissues of LUAD patients was lower than that in the adjacent tissues(P<0.000 1). The total survival time and progression-free survival(PFS) of ADH-1A positive group were longer than those of ADH-1A negative group(P<0.01). Overexpression of ADH-1A could inhibit the proliferation,migration and invasion ability of A549 cells(P<0.000 1). Gender being female and ADH-1A being negative were risk factors for the shortened overall survival period of LUAD patients [hazard ratios(HR) were 1.686 and 0.501,95% confidence intervals(CI) were 1.112-2.555 and 0.328-0.764,P<0.05]. Conclusions ADH-1A is lowly expressed in the cancer tissues of LUAD patients. Upregulation of its expression can inhibit the proliferation and invasion ability of LUAD cells,or it may serve as a potential prognostic marker and therapeutic target for LUAD.

Key words: Alcohol dehydrogenase 1A, Lung adenocarcinoma, Cell function experiment, Survival analysis

中图分类号: